Open Account
Demo Account
About Us
Real-time Quotes & News
Market Analysis
Economic Calendar
Daily Market Analysis
Trading Platform
Platform Overview
How To Use
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
繁
简
EN
User Login
Open Account
Demo Account
繁
简
EN
User Login
Open Account
Demo Account
About Us
About Aspire
Features of Aspire
Real-time Quotes & News
Real-time Quotes
Real-time News
Market Analysis
Economic Calendar
Market Analysis
Trading Platform
Meta Trader 5
Platform Features
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
About Us
Terms
Metals Market
Trading Platform
Market Analysis
Promotion
FAQ
Contact
繁
简
EN
US July Challenger job-cut report due in 10 minutes.
2026-08-06
US July Challenger job-cut report due in 10 minutes.
Back
Other News
2026-08-06
Key News 1. The list of Hong Kong stocks eligible for the Shanghai-Hong Kong Stock Connect has been adjusted, with MINIMAX-W, Luxshare Precision, and Sanhuan Group added. Individual Stock News 1. Luye Pharma (02186.HK): Its innovative drug LY03015
Key News 1. The list of Hong Kong stocks eligible for the Shanghai-Hong Kong Stock Connect has been adjusted, with MINIMAX-W, Luxshare Precision, and Sanhuan Group added. Individual Stock News 1. Luye Pharma (02186.HK): Its innovative drug LY03015 (VMAT2 inhibitor/Sigma-1R agonist) has successfully completed bridging clinical trials in the United States. 2. Jiaoge Pengyou Holdings (01450.HK): It expects to record a net profit of approximately RMB 86 million to RMB 93 million in the first half of 2026, compared to approximately RMB 56.4 million in the first half of 2025, representing a year-on-year increase of approximately 52.6% to 65.0%. 3. Flat Glass (06865.HK): The company signed an equity transfer agreement with Yihe Investment. According to the agreement, the company agreed to acquire, and Yihe Investment agreed to sell, 60% of the equity of Shanghai Fulai Ruicheng, for a total transaction price of RMB 60,039,859.73. 4. China Shengmu (01432.HK): For the six months ended June 30, 2026, the company expects to record a profit between RMB15 million and RMB25 million; the profit attributable to owners of the company is expected to be no less than RMB60 million, achieving a turnaround from loss to profit. 5. CSPC Pharmaceutical Group (01093.HK): Received a US$10 million milestone payment from AstraZeneca for exercising its licensing option for one of the PCC projects under the terms of the agreement, marking the steady progress of the relevant R&D work under the agreement as planned. 6. CIFI Holdings Group (00884.HK): For the first seven months, cumulative contracted sales amounted to approximately RMB5.64 billion and contracted sales area was approximately 587,300 square meters, with an average contracted sales price of approximately RMB11,200 per square meter, and contracted sales attributable to shareholders of the company amounted to approximately RMB3.03 billion.
2026-08-06
China A-share software development sector rallied intraday; Fanwei Network hit the daily price limit, while AsiaInfo Security, Topsec, Ren Zixing, Sifang Jingchuang and Yongxin Zhicheng are also advanced.
China A-share software development sector rallied intraday; Fanwei Network hit the daily price limit, while AsiaInfo Security, Topsec, Ren Zixing, Sifang Jingchuang and Yongxin Zhicheng are also advanced.
Chat with us
, powered by
LiveChat